Figure 2.
A, Overall survival and B, biochemical progression‐free survival for chemo‐naïve and post‐chemo patients with mCRPC treated with abiraterone acetate
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.